158 related articles for article (PubMed ID: 32926750)
1. Racial disparities in local therapy for early stage non-small-cell lung cancer.
Lutfi W; Martinez-Meehan D; Sultan I; Evans N; Dhupar R; Luketich JD; Christie NA; Okusanya OT
J Surg Oncol; 2020 Dec; 122(8):1815-1820. PubMed ID: 32926750
[TBL] [Abstract][Full Text] [Related]
2. Association between race and survival of patients with non--small-cell lung cancer in the United States veterans affairs population.
Ganti AK; Subbiah SP; Kessinger A; Gonsalves WI; Silberstein PT; Loberiza FR
Clin Lung Cancer; 2014 Mar; 15(2):152-8. PubMed ID: 24361249
[TBL] [Abstract][Full Text] [Related]
3. Disparities in the Treatment and Outcome of Stage I Non-Small-Cell Lung Cancer in the 21st Century.
Dalwadi SM; Lewis GD; Bernicker EH; Butler EB; Teh BS; Farach AM
Clin Lung Cancer; 2019 May; 20(3):194-200. PubMed ID: 30655194
[TBL] [Abstract][Full Text] [Related]
4. Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area.
Hua X; Ward KC; Gillespie TW; Lipscomb J; Goodman M
J Community Health; 2014 Aug; 39(4):696-705. PubMed ID: 24346819
[TBL] [Abstract][Full Text] [Related]
5. Persistence of racial disparities in early-stage lung cancer treatment.
Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
[TBL] [Abstract][Full Text] [Related]
6. Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer.
Williams CD; Stechuchak KM; Zullig LL; Provenzale D; Kelley MJ
J Clin Oncol; 2013 Feb; 31(4):475-81. PubMed ID: 23269988
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Differences in Lung Cancer Surgical Stage: An STS Database Study.
Weksler B; Kosinski AS; Burfeind WR; Silvestry SC; Sullivan J; D'Amico TA
Thorac Cardiovasc Surg; 2015 Oct; 63(7):538-43. PubMed ID: 25984780
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
Chen H; Laba JM; Boldt RG; Goodman CD; Palma DA; Senan S; Louie AV
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):186-194. PubMed ID: 29619964
[TBL] [Abstract][Full Text] [Related]
9. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina.
Esnaola NF; Gebregziabher M; Knott K; Finney C; Silvestri GA; Reed CE; Ford ME
Ann Thorac Surg; 2008 Jul; 86(1):220-6; discussion 227. PubMed ID: 18573427
[TBL] [Abstract][Full Text] [Related]
10. The effect of race on invasive staging and surgery in non-small-cell lung cancer.
Lathan CS; Neville BA; Earle CC
J Clin Oncol; 2006 Jan; 24(3):413-8. PubMed ID: 16365180
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
Chang JY; Mehran RJ; Feng L; Verma V; Liao Z; Welsh JW; Lin SH; O'Reilly MS; Jeter MD; Balter PA; McRae SE; Berry D; Heymach JV; Roth JA;
Lancet Oncol; 2021 Oct; 22(10):1448-1457. PubMed ID: 34529930
[TBL] [Abstract][Full Text] [Related]
12. Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer.
Virgo KS; Little AG; Fedewa SA; Chen AY; Flanders WD; Ward EM
J Am Coll Surg; 2011 Nov; 213(5):633-43. PubMed ID: 21907598
[TBL] [Abstract][Full Text] [Related]
13. Ethnic disparities in the treatment of stage I non-small cell lung cancer.
Wisnivesky JP; McGinn T; Henschke C; Hebert P; Iannuzzi MC; Halm EA
Am J Respir Crit Care Med; 2005 May; 171(10):1158-63. PubMed ID: 15735053
[TBL] [Abstract][Full Text] [Related]
14. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
[TBL] [Abstract][Full Text] [Related]
15. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
[TBL] [Abstract][Full Text] [Related]
16. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer.
Mulligan CR; Meram AD; Proctor CD; Wu H; Zhu K; Marrogi AJ
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):25-31. PubMed ID: 16434582
[TBL] [Abstract][Full Text] [Related]
17. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
Mahmood S; Bilal H; Faivre-Finn C; Shah R
Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):845-53. PubMed ID: 23900381
[TBL] [Abstract][Full Text] [Related]
18. Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.
Al-Ahmadi A; Ardeshir-Larijani F; Fu P; Cao S; Lipka MB; Dowlati A; Bruno DS
Clin Lung Cancer; 2021 Jan; 22(1):16-22.e1. PubMed ID: 33397584
[TBL] [Abstract][Full Text] [Related]
19. Comparing Treatment Strategies for Stage I Small-cell lung Cancer.
Paximadis P; Beebe-Dimmer JL; George J; Schwartz AG; Wozniak A; Gadgeel S
Clin Lung Cancer; 2018 Sep; 19(5):e559-e565. PubMed ID: 29656869
[TBL] [Abstract][Full Text] [Related]
20. Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England.
Khakwani A; Harden S; Beckett P; Baldwin D; Navani N; West D; Hubbard R
Thorax; 2020 Mar; 75(3):237-243. PubMed ID: 31879316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
